110 related articles for article (PubMed ID: 12847315)
21. The role of multimodal therapy in patients with local and regional neuroblastoma.
Evans AE; D'Angio GJ; Koop CE
J Pediatr Surg; 1984 Feb; 19(1):77-80. PubMed ID: 6366182
[TBL] [Abstract][Full Text] [Related]
22. [Peripheral neurogenic tumors--surgical therapy of neuroblastoma. Review and personal results].
Prokop A; Pichlmaier H; Berthold F
Zentralbl Chir; 1993; 118(6):315-21. PubMed ID: 8342338
[TBL] [Abstract][Full Text] [Related]
23. Influence of image-defined risk factors on the outcome of patients with localised neuroblastoma. A report from the LNESG1 study of the European International Society of Paediatric Oncology Neuroblastoma Group.
Monclair T; Mosseri V; Cecchetto G; De Bernardi B; Michon J; Holmes K
Pediatr Blood Cancer; 2015 Sep; 62(9):1536-42. PubMed ID: 25663103
[TBL] [Abstract][Full Text] [Related]
24. Improved prognosis for infants with stage IV neuroblastoma.
Kretschmar CS; Frantz CN; Rosen EM; Cassady JR; Levey R; Sallan SE
J Clin Oncol; 1984 Jul; 2(7):799-803. PubMed ID: 6737020
[TBL] [Abstract][Full Text] [Related]
25. Treatment of neuroblastoma.
Evans AE
Cancer; 1972 Dec; 30(6):1595-9. PubMed ID: 4641765
[No Abstract] [Full Text] [Related]
26. Neuroblastoma involvement of the falx cerebri.
Quackenbush KE; Luna-Fineman S; Magee JF; Gundogan M; Golobi M; Irie T; Fernandez CV
Pediatr Blood Cancer; 2009 Dec; 53(7):1337-9. PubMed ID: 19821537
[TBL] [Abstract][Full Text] [Related]
27. Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Bowman LC; Castleberry RP; Cantor A; Joshi V; Cohn SL; Smith EI; Yu A; Brodeur GM; Hayes FA; Look AT
J Natl Cancer Inst; 1997 Mar; 89(5):373-80. PubMed ID: 9060959
[TBL] [Abstract][Full Text] [Related]
28. Loss of heterozygosity on chromosome 14 in neuroblastoma.
Suzuki T; Mugishima H; Fujisawa T; Okuni M; Okabe I; Yokota J; Terada M
Prog Clin Biol Res; 1991; 366():135-45. PubMed ID: 2068134
[No Abstract] [Full Text] [Related]
29. Localized resectable neuroblastoma: results of the second study of the Italian Cooperative Group for Neuroblastoma.
De Bernardi B; Conte M; Mancini A; Donfrancesco A; Alvisi P; Tomà P; Casale F; Cordero di Montezemolo L; Cornelli PE; Carli M
J Clin Oncol; 1995 Apr; 13(4):884-93. PubMed ID: 7707115
[TBL] [Abstract][Full Text] [Related]
30. Outcome of paratesticular involvement in infants with neuroblastoma.
Tröbs RB; Körholz D; Bennek J
J Pediatr Surg; 2001 Dec; 36(12):E23. PubMed ID: 11733935
[TBL] [Abstract][Full Text] [Related]
31. [Results of neuroblastoma treatment in Austria (1979-1984)].
Mutz I; Urban C; Gadner H; Jürgenssen OA; Zoubek A
Padiatr Padol; 1986; 21(3):269-74. PubMed ID: 3774347
[TBL] [Abstract][Full Text] [Related]
32. Investigational chemotherapy of neuroblastoma.
Helson L
J Fla Med Assoc; 1979 Mar; 66(3):284-7. PubMed ID: 422952
[No Abstract] [Full Text] [Related]
33. Autophagy is associated with chemoresistance in neuroblastoma.
Belounis A; Nyalendo C; Le Gall R; Imbriglio TV; Mahma M; Teira P; Beaunoyer M; Cournoyer S; Haddad E; Vassal G; Sartelet H
BMC Cancer; 2016 Nov; 16(1):891. PubMed ID: 27846885
[TBL] [Abstract][Full Text] [Related]
34. Complete resection is not required in patients with neuroblastoma under 1 year of age.
Kaneko M; Iwakawa M; Ikebukuro K; Ohkawa H
J Pediatr Surg; 1998 Nov; 33(11):1690-4. PubMed ID: 9856897
[TBL] [Abstract][Full Text] [Related]
35. Significance of intratumoral genetic heterogeneity in neuroblastomas.
Brodeur GM
Med Pediatr Oncol; 2002 Feb; 38(2):112-3. PubMed ID: 11813176
[No Abstract] [Full Text] [Related]
36. Phase I dose escalation of iodine-131-metaiodobenzylguanidine with myeloablative chemotherapy and autologous stem-cell transplantation in refractory neuroblastoma: a new approaches to Neuroblastoma Therapy Consortium Study.
Matthay KK; Tan JC; Villablanca JG; Yanik GA; Veatch J; Franc B; Twomey E; Horn B; Reynolds CP; Groshen S; Seeger RC; Maris JM
J Clin Oncol; 2006 Jan; 24(3):500-6. PubMed ID: 16421427
[TBL] [Abstract][Full Text] [Related]
37. The LMCE1 unselected group of stage IV neuroblastoma revisited with a median follow up of 59 months after ABMT.
Philip T; Zucker JM; Bernard JL; Lutz P; Bordigoni P; Plouvier E; Robert A; Roché H; Souillet G; Bouffet E
Prog Clin Biol Res; 1991; 366():517-25. PubMed ID: 2068168
[No Abstract] [Full Text] [Related]
38. Fifteen years' experience of neuroblastoma: a prognostic evaluation according to the Evans and UICC staging systems.
Hata Y; Naito H; Sasaki F; Ohkawa M; Takeda T; Sasaki M; Uchino J
J Pediatr Surg; 1990 Mar; 25(3):326-9. PubMed ID: 2313503
[TBL] [Abstract][Full Text] [Related]
39. Neuroblastoma.
Meir HM; Balawi I; Nayel H; Yousef MK; Badawood S; Al-Mobarak M
Saudi Med J; 2001 Aug; 22(8):674-80. PubMed ID: 11573111
[TBL] [Abstract][Full Text] [Related]
40. [Clinical evaluation of A 1 protocol in advanced neuroblastoma].
Iwafuchi M; Ohsawa Y; Hirota M; Matsuda Y
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1323-8. PubMed ID: 2730045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
